Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 10/24/2025 | PUT | $119.00 | 3,807 | +3,718 | +4,177.53% |
| 10/24/2025 | CALL | $122.00 | 3,567 | +1,976 | +124.20% |
| 10/24/2025 | PUT | $117.00 | 1,038 | +734 | +241.45% |
| 10/24/2025 | CALL | $123.00 | 855 | +326 | +61.63% |
| 01/16/2026 | CALL | $130.00 | 1,927 | +298 | +18.29% |
| 01/16/2026 | PUT | $120.00 | 250 | +250 | |
| 11/07/2025 | CALL | $130.00 | 3,583 | -14 | -0.39% |
| 10/24/2025 | PUT | $124.00 | 87 | -21 | -19.44% |
| 01/16/2026 | CALL | $115.00 | 2,715 | -24 | -0.88% |
| 11/07/2025 | PUT | $115.00 | 3,536 | -28 | -0.79% |
| 10/24/2025 | CALL | $125.00 | 996 | -37 | -3.58% |
| 11/21/2025 | CALL | $120.00 | 3,620 | -140 | -3.72% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.05% | 38.12M | 2.91B |
| Income Fund of America Inc | 2.70% | 33.74M | 2.58B |
| Vanguard 500 Index Fund | 2.32% | 28.99M | 2.21B |
| Dodge & Cox Stock Fund | 2.02% | 25.19M | 1.92B |
| Washington Mutual Investors Fund | 1.57% | 19.64M | 1.5B |
| American Balanced Fund | 1.37% | 17.14M | 1.31B |
| American Mutual Fund Inc | 1.33% | 16.67M | 1.27B |
| Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF | 1.31% | 16.4M | 1.25B |
| Fidelity 500 Index Fund | 1.10% | 13.75M | 1.05B |
| SPDR S&P 500 ETF Trust | 1.08% | 13.5M | 1.03B |
Nurix Initiates DAYBreak™ Pivotal Study of Bexobrutideg in Relapsed or Refractory Chronic Lymphocytic Leukemia
10/22 06:00 am
GlobeNewswire Inc.
Read moreGalapagos kondigt intentie aan om celtherapieactiviteiten af te bouwen als onderdeel van de voortdurende transformatie van het bedrijf
10/21 01:30 am
GlobeNewswire Inc.
Read moreGalapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Company’s Ongoing Transformation
10/21 01:30 am
GlobeNewswire Inc.
Read moreNCBCP Celebrates President & CEO, Melanie L. Campbell's 30 Years of Leadership and Service During the 28th Annual Spirit of Democracy Awards Gala
10/20 03:45 pm
Benzinga
Read moreNurix Therapeutics Reports New Clinical Data from First-in-Class Oral CBL-B Inhibitor, NX-1607, Demonstrating Single-Agent Activity Across Multiple Tumor Types at the European Society for Medical Oncology (ESMO) Congress
10/18 03:00 am
GlobeNewswire Inc.
Read moreUK Health Agency Recommends GSK-Backed ViiV Healthcare's Apretude As Injectable HIV Treatment
10/17 12:43 pm
Benzinga
Read moreMerck's New HIV Treatment Works As Well As Top Drug In Late Trials
10/15 12:23 pm
Benzinga
Read moreMultiple Myeloma CAR-T Market Set for Rapid Growth Driven by BCMA-Targeted Therapies and Innovative Advances
10/08 11:00 am
GlobeNewswire Inc.
Read moreGene Therapy Market Size to Worth USD 58.87 Billion Rising at 20% CAGR by 2034 | Towards Healthcare
10/08 10:00 am
GlobeNewswire Inc.
Read moreImmatics Appoints Venkat Ramanan as Chief Financial Officer
10/01 07:00 am
GlobeNewswire Inc.
Read moreFangzhou’s ‘XingShi’ LLM Featured by Nature News and Xinhua, Showcasing AI Innovation in Chronic Disease Care
09/26 03:47 am
GlobeNewswire Inc.
Read moreTop Security Executives Recognized at the 2025 BayAreaCISO ORBIE Awards
09/25 03:49 pm
GlobeNewswire Inc.
Read moreFangzhou Named ‘Outstanding Growth Story in Hong Kong Stocks’ at China Capital Market Development Forum 2025
09/17 10:44 pm
GlobeNewswire Inc.
Read moreBiotech Sector May Flip to Market Leader by Year-End
09/15 01:25 pm
Investing.com
Read moreAustralia Acute Respiratory Distress Syndrome Market Growth and Company Report 2025-2033 Featuring Silence Therapeutics, Gilead Sciences, Terumo, Getinge, Livanova, Medtronic, Fresenius, Nipro, Pfizer
09/04 11:00 am
GlobeNewswire Inc.
Read morePharming Group appoints Kenneth Lynard as Chief Financial Officer
09/02 01:00 am
GlobeNewswire Inc.
Read moreGildea's Kite Pharma Just Acquired Interius—$350 Million Move Shakes Up Cancer Therapy
08/21 11:45 am
Benzinga
Read moreLigand to Participate in September Investor Conferences
08/19 04:00 pm
GlobeNewswire Inc.
Read moreMacroGenics Revenue Doubles in Q2
08/14 04:21 pm
The Motley Fool
Read moreKymera Revenue Drops 55 Percent in Q2
08/11 07:28 am
The Motley Fool
Read moreTango (TNGX) Q2 Revenue Drops 52%
08/05 08:25 pm
The Motley Fool
Read moreIDEAYA (IDYA) Q2 Net Loss Improves 27%
08/05 04:23 pm
The Motley Fool
Read moreMCL1 Inhibitor Drugs Clinical Trials & Market Opportunity Report 2025: Over 12 ML1 Inhibitor Drugs In Clinical Trials
08/05 04:28 am
GlobeNewswire Inc.
Read moreGilead's Newly Approved HIV Prevention Drug Poised To Add Billions To Future Sales
07/25 12:12 pm
Benzinga
Read moreINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD
07/06 10:00 am
GlobeNewswire Inc.
Read moreWhy Gilead Scinces Stock Tumbled on Tuesday
06/10 05:22 pm
The Motley Fool
Read more2 Stocks, 100%+ Combined Gains - All From Spotting Mispricing Before the Crowd
06/08 03:45 am
Investing.com
Read moreNurix Therapeutics to Host a Webcast Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of Bexobrutideg (NX-5948) Being Presented at the 30th European Hematology Association Congress (EHA2025)
06/06 07:00 am
GlobeNewswire Inc.
Read moreXilio Therapeutics Announces Closing of $50.0 Million Public Offering
06/05 06:38 pm
GlobeNewswire Inc.
Read morePenicillin Market Research Report 2025 - Global $12.5+ Bn Trends, Opportunities, and Forecasts, 2020-2030F
05/29 10:58 am
GlobeNewswire Inc.
Read moreMerus annonce ses résultats financiers pour le premier trimestre 2025 et fait le point sur ses activités
05/09 10:46 am
GlobeNewswire Inc.
Read moreNurix Therapeutics Presents Data at the AACR 2025 Annual Meeting Highlighting the Transformative Potential of Its Proprietary DEL-AI Platform Leveraging Machine Learning to Speed the Discovery of Novel Drugs
04/28 04:00 pm
GlobeNewswire Inc.
Read moreGilead Cancer Drug Combined With Merck's Drug Effective In Difficult To Treat Type Of Breast Cancer
04/21 02:49 pm
Benzinga
Read more2 High-Yielding ETFs Retirees Can Safely Build Their Portfolios Around
04/17 05:45 am
The Motley Fool
Read more2 Top Dividend Stocks That Could Set You Up for Life
04/09 07:00 am
The Motley Fool
Read moreIs Vertex Pharmaceuticals Stock a Buy?
04/08 09:45 am
The Motley Fool
Read moreMinimal Residual Disease Testing Market Forecast Report, 2025-2030 - Precision Medicine and Early Relapse Detection Drive MRD Testing Demand Worldwide
04/08 04:48 am
GlobeNewswire Inc.
Read more3 Stocks Leading Healthcare’s Comeback as Wall Street Turns Defensive
04/02 12:14 pm
Investing.com
Read morePharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
03/21 12:31 pm
Benzinga
Read moreBispecific Antibody Market Opportunity, Drug Dosage, Patent, Price, Sales & Clinical Trials Insight 2030: New Report Highlights 600+ Bispecific Antibodies in Clinical Trials Worldwide
03/12 08:48 am
GlobeNewswire Inc.
Read moreThe Top Nasdaq-100 Stock in 2025 Has Nothing to Do With Artificial Intelligence (AI)
03/11 04:20 am
The Motley Fool
Read moreNon-Small Cell Lung Cancer Market Set for Significant Growth Across the 7MM During the Study Period (2025-2034) Due to the Rising Novel Therapeutic Options | DelveInsight
02/26 02:00 pm
GlobeNewswire Inc.
Read moreQuestex’s Fierce Pharma Unveils the Conference Program for the Inaugural Fierce Pharma Engage, Over 100 Speakers Confirmed to Deliver Unparalleled Education
02/24 11:00 am
GlobeNewswire Inc.
Read moreWhy Gilead Sciences Stock Is Jumping Today
02/12 01:21 pm
The Motley Fool
Read moreGilead Sciences Beats Q4 EPS Forecast
02/11 05:40 pm
The Motley Fool
Read more3 Fabulous Dividend Stocks to Buy in February
02/09 03:30 pm
The Motley Fool
Read moreThese 2 Dividend Stocks Are Absolute Bargains Right Now
02/08 09:30 am
The Motley Fool
Read more3 Top AI-Powered Biotech Stocks to Buy in February
02/06 10:45 am
The Motley Fool
Read moreGlobal Pharma & Biotech CRM Software Market To Surpass Valuation of US$ 20.0 Billion by 2033 | Astute Analytica
01/17 04:30 am
GlobeNewswire Inc.
Read more